Printer Friendly

ALPHA-BETA TECHNOLOGY RAISES $2,160,000 THROUGH EXERCISE OF OVER-ALLOTMENT

 WORCESTER, Mass., Dec. 2 /PRNewswire/ -- Alpha-Beta Technology, Inc. (NASDAQ: ABTI) today announced that the underwriters of the company's recent public offering have purchased 72,000 of the 195,000 shares of common stock available to the underwriters to cover over-allotments. Including the over-allotment shares, a total of 1,372,000 shares were sold for $30.00 per share, providing Alpha-Beta with gross proceeds of $41,160,000. Alex. Brown & Sons Incorporated, Kidder, Peabody & Co., Incorporated and Vector Securities International, Inc. managed the offering.
 Alpha-Beta Technology, Inc. is developing a novel class of proprietary pharmaceutical products composed of complex carbohydrates. The company's therapeutic products are designed to prevent and treat infection and certain inflammatory diseases and to reduce cholesterol. The company's lead product, Betafectin(TM) (PGG-Glucan), is a proprietary carbohydrate immunotherapeutic targeted for the prevention and treatment of infection.
 -0- 12/2/93
 /CONTACT: Braden M. Bohrmann, chief financial officer of Alpha-Beta Technology, 508-798-6900; or Robert Gottlieb, senior vice president of Feinstein Partners, 617-577-8110, for Alpha-Beta Technology/
 (ABTI)


CO: Alpha-Beta Technology, Inc. ST: Massachusetts IN: MTC SU:

JL-DJ -- NE020 -- 0022 12/02/93 17:59 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 2, 1993
Words:185
Previous Article:NSC CORPORATION ANNOUNCES SPECIAL CASH DIVIDEND DISTRIBUTION TO SHAREHOLDERS
Next Article:AMERICAN STOCK EXCHANGE DAILY REPORT
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters